Abivax SA's total assets for Q3 2024 were €6.85B, a decrease of -3.30% from the previous quarter. DE:2X1 total liabilities were €4.40B for the fiscal quarter, a -2.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.